NeoChord Crosses 100th Patient Milestone; Appoints Michael Dale to Board of Directors

EDEN PRAIRIE, MN, April 4, 2014—NeoChord Inc., a developer of minimally invasive devices and procedures for mitral valve repair, today announced the treatment of its 100th patient.  “This is an important achievement for our Company, and it coincides with a continuing upsurge in the number of patients scheduled across Europe for the procedure” said Giovanni Speziali, MD, NeoChord’s Chief Medical Officer. 

PDF:  NeoChord Crosses 100th Patient Milestone -Appoints Michael Dale to Board of Directors